We found that treatment of the selected PCa and BPH cell lines with ALCAR resulted in decreased production and release of pro-inflammatory/pro-angiogenic cytokines, such as TNF-α, CCL2, IL-6, CXCL12, CXCL8 and VEGF. Here, IL6 is linked to benign prostatic hyperplasia.